GSK3-beta as a candidate therapeutic target in soft tissue sarcomas

Abstract Soft tissue sarcoma (STS) is a predominantly fatal rare malignancy with inadequate treatment options. Glycogen synthase kinase 3β (GSK-3β) is an emerging target in human malignancies. Its therapeutic relevance in STS is unknown. We analyzed the prognostic impact of GSK-3β gene and protein e...

Full description

Bibliographic Details

Published in:	Journal of Hematology & Oncology
Main Authors:	S. Verbeke, R. Perret, V. Chaire, E. Richard, V. Velasco, F. Giles, L. Cavalcante, A. Italiano
Format:	Article
Language:	English
Published:	BMC 2021-12-01
Subjects:	Glycogen synthase kinase 3β Soft tissue sarcomas 9-ING-41
Online Access:	https://doi.org/10.1186/s13045-021-01215-x